Status:
WITHDRAWN
Comparison of Corneal Aberrations and Visual Outcomes in AcrySof IQ Toric Patients Versus Limbal Relaxing Incision (LRI) Patients
Lead Sponsor:
Alcon Research
Conditions:
Cataracts
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
A prospective evaluation of postoperative corneal aberrations and visual parameters in patients assigned to either an AcrySof IQ Toric intraocular lens (IOL) group or a group implanted with a SN60WF I...
Eligibility Criteria
Inclusion
- operable cataracts
- good ocular health
- 0.5 D to 2.0 D of corneal astigmatism
Exclusion
- \> 2.0 D astigmatism
- irregular astigmatism
- prior or ongoing corneal disease or scarring
- history of ocular disease
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00929747
Start Date
June 1 2009
End Date
October 1 2009
Last Update
April 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alcon Call Center for Trial Locations
Fort Worth, Texas, United States, 76134